The District of Columbia Alcoholic Beverage and Cannabis Board has ordered a 30-day suspension of KLM, LLC, operating as Doobie District, for dispensing medical cannabis to unqualified buyers and falsifying records in the state's tracking system. This action, detailed in Order No. 2026-211 issued February 11, 2026, underscores the strict oversight of medical cannabis distribution to protect patient access and prevent diversion. The U Street retailer at 1526 U Street NW now faces operational downtime and mandatory training.
Undercover Probe Uncovers Verification Lapses
An investigation began on May 9, 2025, after the Alcoholic Beverage and Cannabis Administration received tips about unauthorized medical cannabis sales at Doobie District. Undercover agents made two controlled purchases, where staff completed transactions without checking for medical cards or caregiver status. The products, sourced from licensed cultivators, bore labels with a Doobie District employee's name and patient ID, not the buyers' information.
METRC Manipulation Exposes Overselling
Analysis of the METRC seed-to-sale system revealed the employee's account exceeded the District's 8-ounce limit per patient over 30 days. Investigators identified two other patient accounts oversold using the same credentials, violating requirements for truthful, real-time entries under 22-C DCMR § 5615.3. The Board sustained charges of dispensing to non-qualified individuals under § 5709.5 and falsified tracking data.
Licensee Response Falls Short of Full Accountability
Owner Peter Murillo stipulated to the facts but contested the penalty at a show cause hearing. The company terminated implicated employees, retrained staff, and added personal oversight of sales volumes. Despite these steps, the Board held the licensee responsible for supervision, considering but rejecting revocation due to possible unaware ownership. Additional requirements include ABCA-approved training within 60 days, with noncompliance risking renewed suspension.
Enforcement Signals Tighter Medical Cannabis Controls
Medical cannabis programs like D.C.'s demand rigorous patient verification to ensure products reach registered users and avoid recreational diversion or black market flows. Seed-to-sale systems such as METRC provide traceability from cultivation to sale, making accurate data entry essential for regulatory compliance. This case highlights the Board's commitment to penalties that deter negligence, potentially influencing other District retailers to strengthen internal protocols amid growing cannabis markets.
